Toggle navigation
Home
Search
Services
Blog
Contact
About
Produce Erwina L-Asparaginase for Clinical Use
Anderson, David M.
Genex Corporation, Gaithersburg, MD, United States
Search 512 grants from David Anderson
Search grants from Genex Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Biometrics
Development of Novel Ophthalmic Antibiotics
In vivo Analysis of DISABLED Function and Interactions in Synaptic Vesicle Cyclin
Identification and characterization Of A Complex Involve
Health Careers Opportunity Program
Recently added grants:
Elucidating SHIP1 in microglia in health and disease
Modulation of innate immune cells to create transplant tolerance
Schistosomiasis at the edge of elimination: characterizing sources of new infections in residual transmission hotspots
Elucidating transmission of plasmids harboring blaKPC among carbapenem-resistant Enterobacteriaceae using long-range sequencing
Role of EPAC Signaling in Melanoma Progression
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067960-000
Application #
3614607
Study Section
Project Start
1986-09-22
Project End
Budget Start
1986-09-22
Budget End
1987-03-23
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Genex Corporation
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877
Related projects
NIH 1987
N43 CM
Produce Erwina L-Asparaginase for Clinical Use
Filpula, David R. / Genex Corporation
NIH 1986
N43 CM
Produce Erwina L-Asparaginase for Clinical Use
Anderson, David M. / Genex Corporation
Comments
Be the first to comment on David Anderson's grant